Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 13;226(5):152091. doi: 10.1016/j.imbio.2021.152091

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Published by Elsevier GmbH.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 3 — Pairwise sequence alignment of SARS-CoV-1 and SARS-CoV-2 showing the position of antigenic sites as predicted using sequence-based (SVMTriP) and structure-based (ElliPro) antigenic sites prediction tools. The site TNLC^333-336 and PDDF^426-429 sites are similar in both SARS-CoV-1 and SARS-CoV-2 while other six antigenic sites have sequence divergence. The antigenic site RISNCVADYSVLYNSASF^357-374 of SARS-CoV-2 has been found to be quite unique as it is not present in SARS-CoV-1 as can be seen in alignment.